Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6X3N

Co-structure of BTK kinase domain with L-005085737 inhibitor

Summary for 6X3N
Entry DOI10.2210/pdb6x3n/pdb
DescriptorTyrosine-protein kinase BTK, 4-{8-amino-3-[(6R,8aS)-3-oxohexahydro-3H-[1,3]oxazolo[3,4-a]pyridin-6-yl]imidazo[1,5-a]pyrazin-1-yl}-N-[4-(trifluoromethyl)pyridin-2-yl]benzamide, 4-[8-azanyl-3-[(2~{S})-1-[4-(dimethylamino)butanoyl]pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-~{N}-(1,3-thiazol-2-yl)benzamide, ... (4 entities in total)
Functional Keywordsbruton tyrosine kinase inhibitor, transferase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight32654.41
Authors
Fischmann, T.O. (deposition date: 2020-05-21, release date: 2020-07-22, Last modification date: 2024-03-06)
Primary citationLiu, J.,Guiadeen, D.,Krikorian, A.,Gao, X.,Wang, J.,Babu Boga, S.,Alhassan, A.B.,Yu, W.,Selyutin, O.,Yu, Y.,Anand, R.,Xu, J.,Kelly, J.,Duffy, J.L.,Liu, S.,Yang, C.,Wu, H.,Cai, J.,Bennett, C.,Maloney, K.M.,Tyagarajan, S.,Gao, Y.D.,Fischmann, T.O.,Presland, J.,Mansueto, M.,Xu, Z.,Leccese, E.,Zhang-Hoover, J.,Knemeyer, I.,Garlisi, C.G.,Stivers, P.,Brandish, P.E.,Hicks, A.,Kim, R.,Kozlowski, J.A.
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes.
Bioorg.Med.Chem.Lett., 30:127390-127390, 2020
Cited by
PubMed: 32738973
DOI: 10.1016/j.bmcl.2020.127390
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.95 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon